Evidence map›Paper›PMID 39890864›Full record

ArticleCommunications medicine2025

Accelerated symptom improvement in Parkinson's disease via remote internet-based optimization of deep brain stimulation therapy: a randomized controlled multicenter trial.

Alireza Gharabaghi, Sergiu Groppa, Marta Navas-Garcia, Alfons Schnitzler, Laura Muñoz-Delgado, Vicky L Marshall, Jessica Karl, Lin Zhang, Ramiro Alvarez, Mary S Feldman and 13 more

Registry-linked trialAbstract read
In one paragraph

Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05269862 (Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05269862 naactive not recruitingnot on this map

Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation

TypeinterventionalSponsorAbbott Medical DevicesRan2022 to 2024Enrolled100ConditionsParkinson DiseaseArmsAbbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature, Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature (virtual clinic and in-clinic sessions)
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Advanced Therapeutics in Parkinson's Disease: What's New?Current neurology and neuroscience reports · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Alireza GharabaghiInstitute for Neuromodulation and Neurotechnology, University Hospital Tübingen (UKT), Faculty of Medicine, University Tübingen, 72076, Tübingen, Germany. alireza.gharabaghi@uni-tuebingen.de.ORCID http://orcid.org/0000-0002-9782-5281
Sergiu GroppaMovement Disorders and Neurostimulation, Biomedical Statistics and Multimodal Signal Processing Unit, Department of Neurology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.ORCID http://orcid.org/0000-0002-2551-5655
Marta Navas-GarciaNeurosurgery Department, La Princesa University Hospital, Madrid, Spain.
Alfons SchnitzlerDepartment of Neurology, and Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.ORCID http://orcid.org/0000-0002-6414-7939
Laura Muñoz-DelgadoUnidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.ORCID http://orcid.org/0000-0002-8818-1824
Vicky L MarshallDepartment of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK.
Jessica KarlDepartment of Neurological Sciences, Rush University, Chicago, IL, USA.
Lin ZhangDepartment of Neurology, University of California, Davis, Sacramento, CA, USA.
Ramiro AlvarezUnidad de Enfermedades Neurodegenerativas, Departamento de Neurociencias, Servicio de Neurologia, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
Mary S FeldmanNeurology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.ORCID http://orcid.org/0000-0003-1589-2833
Michael J SoileauTexas Movement Disorder Specialists, PLLC, Georgetown, TX, USA.ORCID http://orcid.org/0000-0002-3944-1327
Lan LuoDepartment of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1314-4367
S Elizabeth ZauberNeurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Benjamin L WalterCenter for Neurological Restoration, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-8323-6873
Chengyuan WuDepartment of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-3954-2929
Hong LeiDepartment of Neurology, University of Arizona, Tucson, AZ, USA.
Damian M HerzMovement Disorders and Neurostimulation, Biomedical Statistics and Multimodal Signal Processing Unit, Department of Neurology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Ming-Hua ChungAbbott Neuromodulation, Plano, TX, USA.ORCID http://orcid.org/0000-0003-1329-0652
Yagna PathakAbbott Neuromodulation, Plano, TX, USA.ORCID http://orcid.org/0000-0001-5271-9824
Bram BlommeAbbott Neuromodulation, Plano, TX, USA.ORCID http://orcid.org/0000-0002-8913-2346
Binith CheeranAbbott Neuromodulation, Plano, TX, USA.
Corneliu LucaDepartment of Neurology, University of Miami, Miami, FL, USA.
Daniel WeissCenter for Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research, University Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0003-0447-7132

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDeep brain stimulation (DBS) has emerged as an important therapeutic intervention for neurological and neuropsychiatric disorders. After initial programming, clinicians are tasked with fine-tuning DBS parameters through repeated in-person clinic visits. We aimed to evaluate whether DBS patients achieve clinical benefit more rapidly by incorporating remote internet-based adjustment (RIBA) of stimulation parameters into the continuum of care.

methodsWe conducted a randomized controlled multicenter study (ClinicalTrails.gov NCT05269862) involving patients scheduled for de novo implantation with a DBS System to treat Parkinson's Disease. Eligibility criteria included the ability to incorporate RIBA as part of routine follow-up care. Ninety-six patients were randomly assigned in a 1:1 ratio using automated allocation, blocked into groups of 4, allocation concealed, and no stratification. After surgery and initial configuration of stimulation parameters, optimization of DBS settings occurred in the clinic alone (IC) or with additional access to RIBA. The primary outcome assessed differences in the average time to achieve a one-point improvement on the Patient Global Impression of Change score between groups. Patients, caregivers, and outcome assessors were not blinded to group assignment. Most of the data collection took place in the patient's home environment.

resultsAccess to RIBA reduces the time to symptom improvement, with patients reporting 15.1 days faster clinical benefit (after 39.1 (SD 3.3) days in the RIBA group (n = 48) and after 54.2 (SD 3.7) days in the IC group (n = 48)). None of the reported adverse events are related to RIBA.

conclusionsThis study demonstrates safety and efficacy of internet-based adjustment of DBS therapy, while providing clinical benefit earlier than in-clinic optimization of stimulation parameters by increasing patient access to therapy adjustment.

Identifiers

PMID39890864
PMCPMC11785990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.